The study, which was done among vaccinated healthcare professionals in Finland to evaluate vaccine-induced immunity, indicated a very high level of antibody induction against viral spike protein and high titers of neutralizing antibodies following two-dose vaccination with the BNT162b2 mRNA COVID-19 vaccine. The gene discussed is PROS1; the disease is COVID-19.